Total Payments
$17,168
2024 Payments
$75.51
Companies
11
Transactions
45
Medicare Patients
2,176
Medicare Billing
$713,749
Payment Breakdown by Category
Other$14,500 (84.5%)
Food & Beverage$2,000 (11.6%)
Travel$667.97 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,000 | 2 | 46.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,500 | 2 | 37.9% |
| Food and Beverage | $2,000 | 38 | 11.6% |
| Travel and Lodging | $667.97 | 3 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biocompatibles, Inc. | $8,879 | 10 | $0 (2019) |
| Boston Scientific Corporation | $7,691 | 13 | $0 (2022) |
| Tactile Systems Technology Inc | $266.74 | 6 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $124.50 | 5 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $62.77 | 3 | $0 (2024) |
| Incyte Corporation | $43.02 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.54 | 2 | $0 (2023) |
| Celgene Corporation | $19.76 | 1 | $0 (2019) |
| Medtronic, Inc. | $19.11 | 1 | $0 (2023) |
| Almirall LLC | $15.70 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.51 | 3 | SUN PHARMACEUTICAL INDUSTRIES INC. ($43.68) |
| 2023 | $128.60 | 6 | Incyte Corporation ($43.02) |
| 2022 | $165.74 | 4 | Boston Scientific Corporation ($121.01) |
| 2021 | $319.21 | 3 | BOSTON SCIENTIFIC CORPORATION ($319.21) |
| 2020 | $7,090 | 8 | Boston Scientific Corporation ($7,071) |
| 2019 | $8,922 | 12 | Biocompatibles, Inc. ($8,879) |
| 2018 | $142.60 | 1 | Tactile Systems Technology Inc ($142.60) |
| 2017 | $323.84 | 8 | BOSTON SCIENTIFIC CORPORATION ($180.31) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Dermatology | ||||||
| 01/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 11/15/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Dermatology | ||||||
| 11/07/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Dermatology | ||||||
| 10/03/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Dermatology | ||||||
| 10/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/12/2023 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: EndoVenous Therapies | ||||||
| 05/04/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $58.58 | General |
| Category: Varithena_PI | ||||||
| 03/17/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $62.43 | General |
| Category: Varithena_PI | ||||||
| 03/17/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/16/2022 | Almirall LLC | Klisyri (Drug) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Dermatology | ||||||
| 06/16/2021 | BOSTON SCIENTIFIC CORPORATION | VARITHENA (Device) | Food and Beverage | In-kind items and services | $101.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/09/2021 | BOSTON SCIENTIFIC CORPORATION | VARITHENA (Device) | Food and Beverage | In-kind items and services | $117.56 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/08/2021 | BOSTON SCIENTIFIC CORPORATION | VARITHENA (Device) | Food and Beverage | In-kind items and services | $100.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/15/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2020 | Boston Scientific Corporation | GENERAL - VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: VASCULAR | ||||||
| 03/18/2020 | Boston Scientific Corporation | GENERAL - VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: VASCULAR | ||||||
| 01/23/2020 | Boston Scientific Corporation | VARITHENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
| 01/23/2020 | Boston Scientific Corporation | VARITHENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
| 01/23/2020 | Boston Scientific Corporation | VARITHENA (Drug) | Travel and Lodging | Cash or cash equivalent | $422.86 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
| 01/23/2020 | Boston Scientific Corporation | VARITHENA (Drug) | Travel and Lodging | Cash or cash equivalent | $64.80 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
| 01/23/2020 | Boston Scientific Corporation | VARITHENA (Drug) | Food and Beverage | Cash or cash equivalent | $37.33 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
| 12/18/2019 | Biocompatibles, Inc. | VARITHENA (Drug) | Food and Beverage | In-kind items and services | $122.73 | General |
| Category: FOAM SCLEROTHERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 341 | 388 | $254,372 | $92,917 |
| 2022 | 8 | 509 | 599 | $592,670 | $200,744 |
| 2021 | 8 | 558 | 652 | $666,488 | $236,834 |
| 2020 | 8 | 768 | 865 | $522,484 | $183,254 |
Total Patients
2,176
Total Services
2,504
Medicare Billing
$713,749
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 16 | 28 | $77,940 | $30,128 | 38.7% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 16 | 29 | $68,411 | $25,598 | 37.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 172 | 182 | $72,894 | $24,535 | 33.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 35 | 41 | $10,413 | $3,832 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 47 | $9,150 | $3,364 | 36.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $9,115 | $3,141 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 24 | $6,449 | $2,320 | 36.0% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 47 | 79 | $222,069 | $72,057 | 32.4% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 40 | 65 | $208,585 | $71,811 | 34.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 218 | 238 | $99,246 | $34,382 | 34.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 73 | 82 | $21,566 | $7,823 | 36.3% |
| 36476 | Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 16 | 18 | $12,528 | $4,453 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 43 | $12,126 | $4,424 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $9,386 | $3,257 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 36 | $7,164 | $2,537 | 35.4% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2021 | 53 | 95 | $298,335 | $99,546 | 33.4% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2021 | 38 | 58 | $185,717 | $70,863 | 38.2% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2021 | 239 | 254 | $104,968 | $37,971 | 36.2% |
| 93971 | Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers | Office | 2021 | 88 | 93 | $34,727 | $9,387 | 27.0% |
| 36476 | Radiofrequency destruction of insufficient vein of arm or leg, accessed through the skin using imaging guidance | Office | 2021 | 28 | 36 | $23,943 | $9,307 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 40 | $6,910 | $4,130 | 59.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 41 | $4,811 | $2,983 | 62.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $7,077 | $2,646 | 37.4% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2020 | 46 | 89 | $289,962 | $100,238 | 34.6% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 303 | 316 | $130,192 | $44,428 | 34.1% |
About Dr. Lukasz Maj, MD
Dr. Lukasz Maj, MD is a Diagnostic Radiology healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770779282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lukasz Maj, MD has received a total of $17,168 in payments from pharmaceutical and medical device companies, with $75.51 received in 2024. These payments were reported across 45 transactions from 11 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($8,000).
As a Medicare-enrolled provider, Maj has provided services to 2,176 Medicare beneficiaries, totaling 2,504 services with total Medicare billing of $713,749. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Palm Beach Gardens, FL
- Active Since 09/18/2007
- Last Updated 07/23/2021
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1770779282
Products in Payments
- VARITHENA (Drug) $15,904
- VARITHENA (Device) $319.21
- FLEXITOUCH (Device) $266.74
- GENERAL - VASCULAR INTERVENTION (Device) $225.95
- DUPIXENT (Biological) $124.50
- Varithena Administration Pack (Device) $121.01
- ILUMYA (Biological) $45.09
- OPZELURA (Drug) $43.02
- SPEVIGO (Drug) $26.15
- Otezla (Drug) $19.76
- CLOSUREFAST (Device) $19.11
- Odomzo (Drug) $17.68
- Klisyri (Drug) $15.70
- SPIRIVA (Drug) $14.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Palm Beach Gardens
Yuvraj Singh, Md, MD
Diagnostic Radiology — Payments: $6,974
Diagnostic Radiology $6,974
Brian Young, Md, MD
Diagnostic Radiology — Payments: $3,631
Diagnostic Radiology $3,631
Manuel Martorell, Md, MD
Diagnostic Radiology — Payments: $2,416
Diagnostic Radiology $2,416
Jaime Toro, Md, MD
Diagnostic Radiology — Payments: $1,581
Diagnostic Radiology $1,581
Barry Simon, M.d, M.D
Diagnostic Radiology — Payments: $867.02
Diagnostic Radiology $867.02